Dual-release compositions of a cyclooxygenase-2 inhibitor
US7220434B2 · kind B2 · utility
9Cited by
3References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2000 |
| Grant date | May 22, 2007 |
| Priority date | — |
| Expiry date | Dec 22, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1635
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising a selective cyclooxygenase-2 inhibitory drug of low water solubility, for example celecoxib, in an immediate-release fraction and a controlled-release, slow-release, programmed-release, timed-release, pulse-release, sustained-release or extended-release fraction. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.